This inventor holds 1 USPTO granted patent. Top assignee: Mcgill University. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Robert Francis
Introduction: Robert Francis is an accomplished inventor based in Laval, Canada. He has made significant contributions to the field of chemotherapeutic agents, particularly in the area of protein translation inhibition. His work is vital for the development of new cancer treatments.
Latest Patents: Robert Francis holds a patent for "Chemotherapeutic agents for inhibition of protein translation." This invention focuses on an anti-proliferative target for designing chemotherapeutic agents, which comprises an EIF4A protein with a specific amino acid sequence, as defined in the patent claim. He has 1 patent to his name.
Career Highlights: Robert has dedicated his career to research and innovation in the medical field. His work at McGill University has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations: Robert has collaborated with notable colleagues, including Junichi Tanaka and Marie-Ève Bordeleau. Their combined expertise has contributed to advancements in their research projects.
Conclusion: Robert Francis exemplifies the spirit of innovation in the medical field through his groundbreaking work on chemotherapeutic agents. His contributions are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile